SIR-Anticoagulant therapy has become more commonly prescribed for people of 65 years and over following the widening of its clinical indications to include thromboembolic prophylaxis in atrial Wbrillation [1]. Due to its narrow therapeutic index, and the intra-individual variation in dose requirements, there is a need to monitor the level of anticoagulation in each patient. Patients have, in the UK, traditionally been monitored at hospital based anticoagulation clinics. More recently, a general practice based service has evolved. The more recent marketing of small portable devices for near patient testing, and the provision by the NHS of monitoring strips, has enabled patients to monitor their own anticoagulation and, following education, adjust their dose.
probably as a result of increased frequency of testing [2] . There is also some evidence that this reduces the likelihood of major bleeding, and could lead to safer and more effective use of warfarin therapy in older patients [3] . Although older patients require more training in theory, but not in practical matters, than young patients, they are able to master the technique [4] . Near patient testing has also been demonstrated to improve quality of life, empowering patients to organise their time more efWciently and increasing independence [5] . However, studies have been non-randomised, and have tended to include younger patients, selected subjectively as likely to be highly motivated to participate.
In view of the availability and potential beneWts of near patient testing, we set out to assess the effect of age upon the attitudes of anticoagulated patients to adopting this method for monitoring of their anticoagulation.
Fifty-six patients, 11 of them <65 years, consecutive attenders at the Royal Victoria InWrmary Anticoagulation Monitoring Service, who had received warfarin for at least 3 months, completed a structured questionnaire with the help of LS, who is not a member of the clinic staff. Demographic details, reason for and length of anticoagulation treatment, and details of the impact clinic attendance has on them and their activities were recorded. Patients were asked about their interest in near patient testing, were it available. Results are shown in Table 1 . Attending the anticoagulant monitoring clinic is described as enjoyable by many, providing an opportunity for socialising and support. The younger cohort found attendance more inconvenient than the older group. Near patient testing, in which 82% of the younger group and 53% of the older group expressed an interest, has the potential to modify this. Further randomised investigations to determine the cost-effectiveness of the scheme in the context of the UK health service, assessing its effects upon stability of control, complication rates, anticoagulation monitoring clinic costs and quality of life for all ages are indicated. 
